SV2002000058A - Efectos sinergisticos de la amlodipina y de la torvastatina o del metabolito de atorvastatina como base para una terapia combinada - Google Patents
Efectos sinergisticos de la amlodipina y de la torvastatina o del metabolito de atorvastatina como base para una terapia combinadaInfo
- Publication number
- SV2002000058A SV2002000058A SV2000000058A SV2000000058A SV2002000058A SV 2002000058 A SV2002000058 A SV 2002000058A SV 2000000058 A SV2000000058 A SV 2000000058A SV 2000000058 A SV2000000058 A SV 2000000058A SV 2002000058 A SV2002000058 A SV 2002000058A
- Authority
- SV
- El Salvador
- Prior art keywords
- amlodipine
- combination
- atorvastatin
- combined therapy
- torvastatin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA COMBINACION DE AMLODIPINA CON ATORVASTATINA O UN METABOLTO DE LA ATORVASTATINA MUESTRA UN EFECTO ANTIOXIDANTE SINERGICO SOBRE LA PEROXIDACION LIPIDICA EN LAS LIPOPROTEINAS DE BAJA DENSIDAD HUMANAS Y LAS VESICULAS DE MEMBRANA ENRIQUECIDAS CON ACIDOS GRASOS POLIINSATURADOS. LA INHIBICION DEL DAÑO OXI-RADICAL POR ESTA COMBINACION FARMACOLOGICA FUE OBSERVADA A NIVELES TERAPEUTICOS DE UNA MANERA NO REPRODUCIBLE POR LA COMBINACION DE AMLODIPINA CON OTRAS ESTATINAS O EL ANTIOXIDANTE NATURAL, LA VITAMINA E. LA BASE DE ESTA ACTIVIDAD POTENTE ES ATRIBUIDA A LAS ESTRUCTURAS QUIMICAS DE ESTOS COMPUESTOS Y SUS INTERACCIONES MOLECULARES CON MOLECULAS FOSFOLIPIDICAS,TAL COMO SE DETERMINA MEDIANTE ANALISIS DE DIFRACCION DE LOS RAYOS X. ESTA TERAPIA COMBINADA PUEDE SER UTILIZADA PARA TRATAR TRASTORNOS CARDIOVASCULARES, ESPECIALMENTE LA ENFERMEDAD CORONARIA,AL INCREMENTAR LA RESISTENCIA DE LA LIPOPROTEINAS DE BAJA DENSIDAD Y DE LAS MEMBRANAS CELULARES VASCULARES CONTRA LA MODIFICACION OXIDATIVA.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13066599P | 1999-04-23 | 1999-04-23 | |
US14530599P | 1999-07-23 | 1999-07-23 | |
US15112199P | 1999-08-27 | 1999-08-27 | |
US16659299P | 1999-11-19 | 1999-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2002000058A true SV2002000058A (es) | 2002-02-05 |
Family
ID=27494873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2000000058A SV2002000058A (es) | 1999-04-23 | 2000-04-25 | Efectos sinergisticos de la amlodipina y de la torvastatina o del metabolito de atorvastatina como base para una terapia combinada |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP1173172B1 (es) |
JP (1) | JP2002542289A (es) |
KR (1) | KR20020024581A (es) |
CN (1) | CN1351492A (es) |
AP (1) | AP2001002324A0 (es) |
AT (1) | ATE314846T1 (es) |
AU (1) | AU4647000A (es) |
BG (1) | BG106115A (es) |
BR (1) | BR0010689A (es) |
CA (1) | CA2370639A1 (es) |
CZ (1) | CZ20013793A3 (es) |
DE (1) | DE60025344T2 (es) |
DK (1) | DK1173172T3 (es) |
EA (1) | EA004435B1 (es) |
EE (1) | EE200100555A (es) |
ES (1) | ES2256005T3 (es) |
HK (1) | HK1043741A1 (es) |
HU (1) | HUP0201016A3 (es) |
IL (1) | IL146085A0 (es) |
IS (1) | IS6118A (es) |
NO (1) | NO20015128L (es) |
OA (1) | OA11870A (es) |
PE (1) | PE20010055A1 (es) |
PL (1) | PL351408A1 (es) |
PT (1) | PT1173172E (es) |
SK (1) | SK15382001A3 (es) |
SV (1) | SV2002000058A (es) |
TN (1) | TNSN00085A1 (es) |
UY (1) | UY26118A1 (es) |
WO (1) | WO2000064443A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20030324A1 (es) * | 2001-07-31 | 2003-04-03 | Warner Lambert Co | Composiciones farmaceuticas de amlodipina y atorvastatina |
CN100430057C (zh) * | 2005-04-08 | 2008-11-05 | 石药集团中奇制药技术(石家庄)有限公司 | 左旋氨氯地平和阿托伐他汀的药物组合物 |
KR101467110B1 (ko) * | 2013-08-01 | 2014-11-28 | 한국방송공사 | 코로나링을 구비한 지선애자 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5385929A (en) * | 1994-05-04 | 1995-01-31 | Warner-Lambert Company | [(Hydroxyphenylamino) carbonyl] pyrroles |
GT199800127A (es) * | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. |
-
2000
- 2000-04-18 IL IL14608500A patent/IL146085A0/xx unknown
- 2000-04-18 JP JP2000613434A patent/JP2002542289A/ja not_active Withdrawn
- 2000-04-18 EP EP00928200A patent/EP1173172B1/en not_active Expired - Lifetime
- 2000-04-18 DE DE60025344T patent/DE60025344T2/de not_active Expired - Fee Related
- 2000-04-18 AT AT00928200T patent/ATE314846T1/de not_active IP Right Cessation
- 2000-04-18 AP APAP/P/2001/002324A patent/AP2001002324A0/en unknown
- 2000-04-18 CA CA002370639A patent/CA2370639A1/en not_active Abandoned
- 2000-04-18 HU HU0201016A patent/HUP0201016A3/hu unknown
- 2000-04-18 OA OA1200100272A patent/OA11870A/en unknown
- 2000-04-18 EA EA200101112A patent/EA004435B1/ru not_active IP Right Cessation
- 2000-04-18 PT PT00928200T patent/PT1173172E/pt unknown
- 2000-04-18 PL PL00351408A patent/PL351408A1/xx unknown
- 2000-04-18 CN CN00807935A patent/CN1351492A/zh active Pending
- 2000-04-18 EE EEP200100555A patent/EE200100555A/xx unknown
- 2000-04-18 ES ES00928200T patent/ES2256005T3/es not_active Expired - Lifetime
- 2000-04-18 DK DK00928200T patent/DK1173172T3/da active
- 2000-04-18 AU AU46470/00A patent/AU4647000A/en not_active Abandoned
- 2000-04-18 SK SK1538-2001A patent/SK15382001A3/sk unknown
- 2000-04-18 KR KR1020017013547A patent/KR20020024581A/ko not_active Application Discontinuation
- 2000-04-18 WO PCT/US2000/010465 patent/WO2000064443A1/en active IP Right Grant
- 2000-04-18 BR BR0010689-5A patent/BR0010689A/pt not_active IP Right Cessation
- 2000-04-18 CZ CZ20013793A patent/CZ20013793A3/cs unknown
- 2000-04-19 PE PE2000000374A patent/PE20010055A1/es not_active Application Discontinuation
- 2000-04-21 TN TNTNSN00085A patent/TNSN00085A1/fr unknown
- 2000-04-24 UY UY26118A patent/UY26118A1/es unknown
- 2000-04-25 SV SV2000000058A patent/SV2002000058A/es unknown
-
2001
- 2001-10-19 IS IS6118A patent/IS6118A/is unknown
- 2001-10-19 NO NO20015128A patent/NO20015128L/no not_active Application Discontinuation
- 2001-11-16 BG BG106115A patent/BG106115A/bg unknown
-
2002
- 2002-07-19 HK HK02105343.1A patent/HK1043741A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2108125T3 (es) | Aporte in vivo de factores activos por implantes de celulas cultivadas conjuntamente. | |
ES2660204T3 (es) | Método de reparación tisular | |
ES2155192T3 (es) | Productos de toallitas de papel que contienen suavizantes y glicol de silicona. | |
GT199900102A (es) | Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen. | |
GT200500339A (es) | Compuestos y derivados de dibencil amina | |
ES2037908T3 (es) | Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida. | |
AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
GT199700015A (es) | Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion. | |
DOP2000000064A (es) | Envases | |
SV2004001691A (es) | Nuevos derivados de fluoroglicosidos aromaticos, medicamentos que contienen compuestos y sus usos | |
ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
ES2128803T3 (es) | Retractor quirurgico. | |
SV2006002100A (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos ref. p-sv-78.159/msu | |
ECSP056020A (es) | Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion | |
ECSP077153A (es) | Métodos y composiciones para la cicatrización de heridas | |
SV2002000058A (es) | Efectos sinergisticos de la amlodipina y de la torvastatina o del metabolito de atorvastatina como base para una terapia combinada | |
CR9012A (es) | Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4-tetrahidroquinolina | |
AR013613A1 (es) | MICROESFERAS FARMACÉUTICAS DE ÁCIDO VALPROICO PARA LA ADMINISTRACIoN ORAL, PROCEDIMIENTO PARA PREPARARLAS Y FORMAS FARMACÉUTICAS QUE LAS CONTIENEN | |
AR020781A1 (es) | Uso de composicion oftalmica | |
UY27418A1 (es) | Formulaciones en combinación de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilización | |
ES2422173T3 (es) | Composiciones que contienen aecuorina y procedimientos de uso de las mismas | |
PA8807001A1 (es) | Nanoparticulas con superficie modificada | |
AR032074A1 (es) | Microparticulas lipidicas por micronizacion criogenica | |
UY27956A1 (es) | Una composicion farmaceutica de liposomas de tamano pequeno y metodo de preparacion | |
ES2121700B1 (es) | Sistema para el cultivo de pulpos. |